Date of Decision: February 3, 2020
Allegations: Supplied controlled drugs (diazepam, methadone, buprenorphine) without prescriptions.
Failed to endorse FP10MDA prescriptions.
Failed to maintain appropriate pharmacy records.
Maintained inaccurate Responsible Pharmacist log.
Received a police caution for unlawful possession of a large quantity of controlled drugs.
Failed to notify the GPhC of the police caution within seven days.
Was suffering from adverse physical or mental health.
Outcome: Suspension extended for 12 months
Read more »
Date of Decision: June 26, 2025
Allegations: Prescribing amitriptyline to vulnerable patients without verifying the information provided.
Failing to consult with patients' GPs or obtain independent confirmation of diagnoses or medical history.
Inadequate risk assessment and safeguarding of vulnerable patients.
Over-reliance on online questionnaires in prescribing decisions.
Outcome: Warning issued, published on the register for 12 months
Read more »
Date of Decision: June 26, 2025
Allegations: Failed to ensure safe prescribing practices as Responsible and Superintendent Pharmacist at UK Meds Ltd
Oversaw the prescribing and dispensing of vast quantities of high-risk medicines based on inadequate patient information and without proper clinical oversight
Allowed a transactional model of care contrary to GPhC and GMC guidelines
Dispensed specific prescriptions without confirming they adhered to clinical guidance
Breached multiple GPhC professional and pharmacy premises standards
Outcome: Suspension (four months)
Read more »
Date of Decision: January 14, 2019
Allegations: The registrant was found to be suffering from adverse physical or mental health conditions, as detailed in Schedule 1.
The nature of the illness was such that it impaired the registrant’s ability to practise safely and effectively as a pharmacist.
Outcome: Fitness to practise found not currently impaired; existing conditions of practice order allowed to lapse.
Read more »
Date of Decision: February 20, 2019
Allegations: Conviction for possession of cannabis, diazepam, and alprazolam
Possession of unlabelled prescription-only medications (Letrozole, Bendroflumethiazide, Zomorph, Aciclovir) without prescriptions
Dishonestly removing medicines from a pharmacy without permission or payment
Reckless consumption of cocaine and MDMA
Smoking cannabis on multiple occasions
Outcome: 12-month suspension with review; interim suspension order continued until substantive order takes effect
Read more »
Date of Decision: June 23, 2025
Allegations: Consumed prescription-only medication without authorisation or a valid prescription.
Supplied prescription-only medicine outside the legitimate supply chain.
Removed Oramorph and Tramadol from the pharmacy without permission.
Entered pharmacy premises out of hours without authorisation.
Made inappropriate and sexually motivated comments to two colleagues (Persons A and B).
Touched both colleagues’ hair inappropriately.
Engaged in sexually motivated conduct seeking gratification or sexual interaction.
Was affected by a medical condition relevant to fitness to practise.
Outcome: Removal from the Register
Read more »
Date of Decision: September 24, 2019
Allegations: The registrant received a police caution for theft by employee.
The registrant’s fitness to practise was alleged to be impaired due to this caution.
Outcome: 6 month suspension
Read more »
Date of Decision: June 20, 2025
Allegations: Failed to follow UK prescribing guidance, including inadequate patient assessments and failure to obtain necessary medical information.
Relied on a basic online questionnaire for prescribing, enabling patients to provide false or misleading information.
Did not contact patients’ GPs before supplying prescription-only medication.
Provided unassessed and unaudited pharmacy services at a distance.
Failed to implement requirements of an Improvement Action Plan within the stipulated timeframe.
Issued around 1800 prescriptions and supplied approximately 9000 inhalers over six months without adequate oversight.
Provided misleading or inaccurate information to GPhC inspectors regarding stock levels and prescription practices.
Admitted to dishonesty and lack of integrity in several instances, including efforts to conceal the true scale of medication supply.
Outcome: Warning
Read more »
Date of Decision: May 23, 2019
Allegations: Inappropriate physical and verbal conduct towards a colleague (Person 9) over an extended period while acting as her mentor.
Comments of a sexual and threatening nature, including suggestions of kidnapping and aggressive behavior.
Repeated boundary violations including physical contact, suggestive gestures, and intimidation.
Failure to maintain appropriate professional conduct and respect within the pharmacy workplace.
Outcome: Conditions on registration for 12 months
Read more »
Date of Decision: June 16, 2025
Allegations: Failure to implement up-to-date SOPs for the sale and supply of high-risk opioid medicines at two pharmacies.
Ordering or allowing the ordering of excessive quantities of Codeine Linctus and Phenergan Elixir, which are liable to misuse and abuse.
Failure to have adequate monitoring or audit systems for the ordering and sale of these high-risk medicines.
Placing unusually large orders for Codeine Phosphate and Co-codamol without adequate justification.
Outcome: 2 month suspension
Read more »
